David Lukton

Array ( [id] => 9552429 [patent_doc_number] => 08759480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Contoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides' [patent_app_type] => utility [patent_app_number] => 13/398419 [patent_app_country] => US [patent_app_date] => 2012-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 54596 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13398419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090232 [patent_doc_number] => 09127044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Cyclic depsipeptides' [patent_app_type] => utility [patent_app_number] => 13/372758 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28261 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323741 [patent_doc_number] => 08658764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Peptide fragments for inducing synthesis of extracellular matrix proteins' [patent_app_type] => utility [patent_app_number] => 13/339606 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7606 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128361 [patent_doc_number] => 20120088725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => '5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 13/327114 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3144 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088725.pdf [firstpage_image] =>[orig_patent_app_number] => 13327114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427832 [patent_doc_number] => 08703909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide' [patent_app_type] => utility [patent_app_number] => 13/316742 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 7323 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056465 [patent_doc_number] => 20120077957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Lactam-Bridged Melanocortin Receptor-Specific Peptides' [patent_app_type] => utility [patent_app_number] => 13/311817 [patent_app_country] => US [patent_app_date] => 2011-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21529 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077957.pdf [firstpage_image] =>[orig_patent_app_number] => 13311817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10528996 [patent_doc_number] => 09255124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Modifications of peptide compositions to increase stability and delivery efficiency' [patent_app_type] => utility [patent_app_number] => 13/305685 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7916 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13305685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199263 [patent_doc_number] => 20120122765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMPOUNDS AND RELATED METHODS FOR MANIPULATING PARP-1-DEPENDENT CELL DEATH' [patent_app_type] => utility [patent_app_number] => 13/294938 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17531 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122765.pdf [firstpage_image] =>[orig_patent_app_number] => 13294938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211166 [patent_doc_number] => 20120129774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/294371 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5024 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129774.pdf [firstpage_image] =>[orig_patent_app_number] => 13294371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173551 [patent_doc_number] => 20120108507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Methods for In Vivo Cell Reprogramming' [patent_app_type] => utility [patent_app_number] => 13/288040 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3972 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108507.pdf [firstpage_image] =>[orig_patent_app_number] => 13288040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982069 [patent_doc_number] => 08513183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Peptide pharmaceutical for oral delivery' [patent_app_type] => utility [patent_app_number] => 13/283055 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10688 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13283055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776364 [patent_doc_number] => 20120039909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'EPIGENETIC MECHANISMS RE-ESTABLISH ACCESS TO LONG-TERM MEMORY AFTER NEURONAL LOSS' [patent_app_type] => utility [patent_app_number] => 13/279636 [patent_app_country] => US [patent_app_date] => 2011-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 20055 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039909.pdf [firstpage_image] =>[orig_patent_app_number] => 13279636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160125 [patent_doc_number] => 20120101037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/274372 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12446 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101037.pdf [firstpage_image] =>[orig_patent_app_number] => 13274372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944419 [patent_doc_number] => 08993720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Methods for the treatment of X-linked hypophosphatemia and related disorders' [patent_app_type] => utility [patent_app_number] => 13/272809 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406681 [patent_doc_number] => 20120238749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME' [patent_app_type] => utility [patent_app_number] => 13/271474 [patent_app_country] => US [patent_app_date] => 2011-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56581 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13271474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140701 [patent_doc_number] => 20120094898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'PEPTIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/271763 [patent_app_country] => US [patent_app_date] => 2011-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17853 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094898.pdf [firstpage_image] =>[orig_patent_app_number] => 13271763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10142243 [patent_doc_number] => 09175042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Cyclosporin analogs' [patent_app_type] => utility [patent_app_number] => 13/270929 [patent_app_country] => US [patent_app_date] => 2011-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6411 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13270929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094065 [patent_doc_number] => 20120082636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/252751 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 18692 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082636.pdf [firstpage_image] =>[orig_patent_app_number] => 13252751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056035 [patent_doc_number] => 20120077749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Biologically Active Peptides' [patent_app_type] => utility [patent_app_number] => 13/238751 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22363 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077749.pdf [firstpage_image] =>[orig_patent_app_number] => 13238751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172120 [patent_doc_number] => 20120107800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'CELL-TARGETING NANOPARTICLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/236567 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5974 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107800.pdf [firstpage_image] =>[orig_patent_app_number] => 13236567 [rel_patent_id] =>[rel_patent_doc_number] =>)